赵淑云,杨英捷,陈景端,黄林
ZHAO Shu yun,YANG Ying jie,CHEN Jing duan,HUANG Lin (Department of Obstetrics and Gynecology,Affiliated Hospital of Guiyang Medical Colege, Guiyang 550004,China )

• 1:贵阳医学院附院妇产科
• 2:贵阳医学院附院妇产科
• 3:贵阳医学院附院妇产科
• 4:贵阳医学院附院妇产科 贵州贵阳550004

摘要(Abstract)：

目的 :研究凋亡相关基因sFas/Apo - 1和Bcl- 2血浆中的表达水平 ,探讨二者在卵巢癌发生发展中的作用及临床应用价值。方法 :采用ELISA法对 2 0例上皮性卵巢癌、19例卵巢良性肿瘤、18例正常人群血浆中sFas/Apo - 1和Bcl- 2水平进行检测。结果 :卵巢癌患者血浆sFas/Apo - 1是 (10 2 5 6 5 2± 1 5 73)ng/L ,明显高于卵巢良性肿瘤组 (6 86 12 0± 1 36 1)ng/L ,和正常人群组 (6 38 2 6 4± 1 2 4 1)ng/L ,差异有极显著意义 (P <0 0 1)。而卵巢良性肿瘤组与正常人群组间差异无显著意义 (P >0 0 5 )。卵巢癌患者血浆Bcl- 2是 (179 14 3±2 6 84 )U/ml,也明显高于卵巢良性肿瘤组 (82 4 71± 1 94 3)U/ml,和正常人群组 (6 6 4 2 0± 1 4 0 1U/ml) ,差异有极显著意义 (P <0 0 1)。卵巢囊肿组与正常人群组间差异也无显著意义 (P >0 0 5 )。血浆sFas/Apo - 1水平诊断卵巢癌的敏感性为 35 % ,特异性为 88 89%。血浆Bcl - 2水平诊断卵巢癌的敏感性为 5 5 % ,特异性为84 6 1%。结论 :Fas/Apo - 1和Bcl- 2基因通过细胞凋亡的调控共同参与了卵巢癌的发生发展 ,对二者的血清学检测有助于卵巢癌的诊治。
Objective:To investigate the role of sFas/Apo-1 and Bcl-2 in plasma in occurrence and progression of ovarian cacinoma and its predictive value.Methods: A prospective double-blinded study was performed.The expression of sFas/Apo-1 and Bcl-2 levels in 20 cases of ovarian cacinoma,19 cases of ovarian cystis and 18 cases of normol wormen were examined with enzyme linked immunoabsorbent assay(ELISA).Results:The expression level of sFas/Apo-1 in ovarian cacinoma(1025 652±1 573 pg/ml)was significantly higher than those in ovarian cystis(686 120±1 361 pg/ml)and in normol(638 264±1 241 pg/ml),P<0 01.Then the expression level of Bcl-2 in ovarian cacinoma(179 143±2 684 Iu/ml)was significantly higher than those in ovarian cystis(82 471±1 943 Iu/ml)and in normol(66 420±1 401 Iu/ml),P<0 01.At the cut point of x±s,the sensitivity and specificity of plasma sFas/Apo-1 on predicting the ovarian cacinoma were 35%,88 89%,respectively.The sensitivity and specificity of plasma Bcl-2 on predicting the ovarian cacinoma were 55%,84 61%,respectively.Conclusion: Both Fas/Apo-1 and Bcl-2 might take part in the occurrence and progression of ovarian cacinoma through regulate apoptosis The plasma sFas/Apo-1 and Bcl-2 levels may be an earlier predictor of ovarian cacinoma,and may be helpful to select chemiotherapy plan.

关键词(KeyWords)： 细胞凋亡;卵巢;癌;酶联免疫吸附测定;基因表达调控,肿瘤
apoptosis; ovary; carcinoma; enzyme-linked immunosorbent assay; gene expression regulation,neoplasm

Abstract:

Keywords:

基金项目(Foundation):

作者(Author): 赵淑云,杨英捷,陈景端,黄林
ZHAO Shu yun,YANG Ying jie,CHEN Jing duan,HUANG Lin (Department of Obstetrics and Gynecology,Affiliated Hospital of Guiyang Medical Colege, Guiyang 550004,China )

Email:

DOI: 10.19367/j.cnki.1000-2707.2002.04.006

参考文献(References)：

• [1]NagataS ,GlosteinP .TheFasdeathfactor[J].Science,1995,267(5203):1449-1445.
• [2]CraigBThompson.Apoptosisinthe pathogenesisandtreatmentofdisease[J].Science,1995,1456-1461.
• [3]李宏军,余莉章,郭应禄Fas系统在肿瘤研究中的应用[J]中华妇产科杂志,1997,35(1):59-61
• [4]倪虹卵巢肿块患者血清中cersB的临床应用[J]国外医学妇产科分册,2000,(4):252-253
• [5]梁惠琪卵巢癌与细胞因子及其受体关系的研究进展[J]国外医学妇产科分册,2000,(6):360-363
• [6]朱锡华Fas系统研究进展[J].中华微生物学和免疫学杂志,1996,16(2):77-82
• [7]YukiihiroA ,YoshinoriO ,SeikoK ,etal.Multiplesubcel lularlocalizationofbc1-2:Detectioninnuclearoutermembraneendoplasicreticulummembraneandmitochon drialmembranes[J].CancerRes,1994,54:2468-2470.
• [8]朱珍道,郭旦敏,胡,等 bcl-2、p53和c-erb-B2基因在卵巢癌中的表达[J]河南肿瘤学杂志,1998,11(4):261.
• [9]李宏军,俞莉章,杨保龙,等.凋亡相关基因产物Fast/Apo-1和bcl-2蛋白在肾癌组织中的表达及意义[J].中华外科杂志,1998,36(7):409.
• [10]陈燕,周剑锋,乐蓓蓓,等.Bcl-2及其家族Bax-X1和Fast/Apo-1,p16的检测在急性白血病中的临床意义[J].癌症,1998,17(5):352.
• [11]娄阁,钱素娟,马玉彦,等.bcl-2、p53、Fas蛋白表达与卵巢上皮癌细胞凋亡的相关性研究[J]现代妇产科进展,1998,7(3):203-205
• [12]严瑞兰,王剑波,惠宏襄,等.抗调亡基因Bcl-2在人卵巢癌表达的免疫组化检测[J].第四军医大学学报,1997,18(2):142-145.
• [13]HenriksenR ,WilanderE ,ObergK .Expressionandprog nosticsignificanceofBcl-2inovariantumors[J].BritishJournalOfCancer,1995,72:1324-1329.
• [14]赖东梅,朱关珍,丰有吉,等.子宫内膜癌bcl-2癌基因的持续表达及其临床意义[J].现代妇产科进展,1998,7(3)210-213.
• [15]Wakahara,Y ,NavaA ,OkamotoT ,etal.Combinationeffectofanti-Fasantibodyandchemotherapeuticdrugsinovariancancercellsinvitro[J].Oncology,1997,54(1):48-54.
• [16]张海鹏,沈铿细胞调亡与卵巢癌研究进展[J].现代妇产科进展,1998,7(1):69-72.

文章评论(Comment)：